- 全部删除
- 您的购物车当前为空
Nebularine (9-(beta-D-Ribofuranosyl)-9H-purine),是一种嘌呤核苷类似物,具有广谱的抗肿瘤活性,针对惰性淋巴恶性肿瘤并诱导凋亡。Nebularine的抗癌机制依赖于抑制DNA合成。
为众多的药物研发团队赋能,
让新药发现更简单!
Nebularine (9-(beta-D-Ribofuranosyl)-9H-purine),是一种嘌呤核苷类似物,具有广谱的抗肿瘤活性,针对惰性淋巴恶性肿瘤并诱导凋亡。Nebularine的抗癌机制依赖于抑制DNA合成。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 166 | In stock | |
5 mg | ¥ 363 | In stock | |
10 mg | ¥ 579 | In stock | |
25 mg | ¥ 1,160 | In stock | |
50 mg | ¥ 1,860 | In stock | |
100 mg | ¥ 2,590 | In stock | |
200 mg | ¥ 3,830 | In stock |
产品描述 | Nebularine (9-(beta-D-Ribofuranosyl)-9H-purine) is a purine nucleoside analog with a broad spectrum of antitumor activity, targeting inert lymphoid malignancies and inducing apoptosis.The anticancer mechanism of Nebularine is dependent on the inhibition of DNA synthesis. |
别名 | 水粉蕈素, 9-(beta-D-Ribofuranosyl)-9H-purine |
分子量 | 252.23 |
分子式 | C10H12N4O4 |
CAS No. | 550-33-4 |
Smiles | OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2cncnc12 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 55 mg/mL (218.05 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容